PAK1 has been reported to mediate drug resistance in lymphomas [190], and targeting PAK1 suppressed the proliferation of chronic myeloid leukemia cells [191]. The gene discussed is PAK1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.